Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model

Abstract

This D. melanogaster-M. abscessus infection/curing methodology may be useful for the rapid evaluation of potential drug candidates. In addition, new combinations using tigecycline and linezolid should be considered as possible next-generation combination therapies to be assessed in higher organisms.